Weight Loss Diet Solutions

In-depth analysis of Garcinia Cambogia Extract market research report offers an forecast period 2019–2025, detail study on market trends and the present-future market state of the Garcinia Cambogia Extract market across the globe with valuable facts and figures. Garcinia Cambogia Extract Market also provides data concerning the rising opportunities within the Garcinia Cambogia Extract market, Trends technologies that may boost these growth trends. Garcinia Cambogia Extract Market report contains a comprehensive summary of Garcinia Cambogia Extract together with definitions, Scope, Application, Production, varieties and CAGR Comparison, Segmentation by Share, Revenue standing and Outlook, Capacity, Consumption, Market Drivers, Production status and Outlook and Opportunities, Export, Import, rising Markets rate of growth.

Get Sample Copy of Garcinia Cambogia Extract Report Here: https://qymarketstudy.com/report/global-garcinia-cambogia-extract-market-98250#request-sample

The report provides a comprehensive analysis of the current situation and future growth prospects of the Garcinia Cambogia Extract industry for 2019-2025. The Report Consider the revenue generated from global sales which helps to calculate market size and report mainly focus on market influencing factors of the Garcinia Cambogia Extract in North America, Europe, Asia-Pacific, South America, and the Middle East Africa.

Market Top Manufacturers Report Cover:

Xi’an Lyphar Biotech
Shaanxi Fuheng (FH) Biotechnology
Shaanxi Guanjie Technology
Wuhan Vanz Pharm
Hunan Kanerga Pharmaceutical Sales
TWO BLUE DIAMONDS
MARUTI FUTURISTIC PHARMA
KINAL GLOBAL CARE
NUTRA GRACE

Market Segment by Types Report Cover:

0.5
0.6
Other

Market Segment by Application Report Cover:

Food Industry
Pharmaceuticals Industry
Other

Inquiry for Buying Report of Garcinia Cambogia Extract Market Here: https://qymarketstudy.com/report/global-garcinia-cambogia-extract-market-98250#inquiry-for-buying

Table of content Covered in Garcinia Cambogia Extract research report:

1 Industry Overview
1.1 Global Garcinia Cambogia Extract Market Overview
1.2 Global Garcinia Cambogia Extract Market Size and Analysis by Regions (2013-2019)
1.3 Classification of Garcinia Cambogia Extract by Product
1.4 Global Garcinia Cambogia Extract Market by End Users/Application

2 Global Garcinia Cambogia Extract Competition Analysis by Players
2.1 Global Garcinia Cambogia Extract Market Size (Million USD) by Players (2013-2019)
2.2 Competitive Status

3 Company (Top Players) Profiles and Key Data

4 Global Garcinia Cambogia Extract Market Size by Product and Application (2013-2019)
4.1 Global Garcinia Cambogia Extract Market Size by Product (2013-2019)
4.2 Global Garcinia Cambogia Extract Market Size by Application (2013-2019)
4.3 Potential Application of Garcinia Cambogia Extract in Future
4.4 Top Consumer / End Users of Garcinia Cambogia Extract

5. Other regionals Garcinia Cambogia Extract Market Size by Product and Application (2013-2019)

6 Global Garcinia Cambogia Extract Market Forecast by Regions, Product and Application (2019-2025)
6.1 Global Garcinia Cambogia Extract Market Size (Million USD) by Regions (2019-2025)
6.2 Global Garcinia Cambogia Extract Market Size by Application (2019-2025)
6.3 Global Garcinia Cambogia Extract Market Size by Product (2019-2025)

7 Global Garcinia Cambogia Extract Market Dynamics
7.1 Global Garcinia Cambogia Extract Market Opportunities
7.2 Global Garcinia Cambogia Extract Challenge and Risk
7.2.1 Competition from Opponents
7.2.2 Downside Risks of Economy
7.3 Global Garcinia Cambogia Extract Market Constraints and Thread
7.4 Global Garcinia Cambogia Extract Market Driving Force

8. Market Effect Factors Analysis

9. Research Finding /Conclusion

Read full Research Report Study: https://qymarketstudy.com/report/global-garcinia-cambogia-extract-market-98250

In the end, report provides the Complete study of every segment like market share by companies, present status, future forecast, research methodology, market size estimation, growth opportunities, and key manufacturers and market effect factors. Also report gives you details about the market research findings and conclusion which helps you to develop profitable market strategies.

About Us:

QYMarketStudy.com is a single destination for all the industry, company and country reports. We have a leading market intelligence team which accredits and provides the reports of some of the top publishers in the field of the technology industry.

Contact Us:

3626 North Hall Street (Two Oak Lawn),
Suite 610,
Dallas, TX 75219, USA
Contact No. +1-214-661-1669
Web: https://www.qymarketstudy.com/
Email: sales@qymarketstudy.com

Fake reviews for items on sites like Amazon are a nuisance at best and downright dangerous at worst.

Despite efforts to tackle the issue, it’s still a big problem for online shopping sites, so it comes as a surprise to learn that this week the Federal Trade Commission (FTC) achieved only its first settlement in proceedings that challenged a merchant’s use of fake, paid-for reviews.

The FTC targeted Cure Encapsulations, Inc. in a case that accused it of paying a third-party website to write and post fake Amazon reviews for its garcinia cambogia weight-loss supplement, and of making unsubstantiated claims for the product.

According to the FTC, the company advertised and sold “Quality Encapsulations Garcinia Cambogia Extract with HCA” capsules on Amazon.com as an appetite-suppressing, fat-blocking, weight-loss pill.

Supplements using garcinia cambogia have been at the center of much debate over the years, with many experts questioning the safety and effectiveness of the fruit extract for the purposes of weight loss.

The FTC said the company paid a website called amazonverifiedreviews.com to write and post reviews of the weight-loss product for its Amazon listing, and also claimed that it asked the reviewers to ensure it maintained a rating of at least 4.3 stars out of a maximum 5.

The reviews, as well as information displayed on the supplement’s product page on Amazon, were described as making “false and unsubstantiated claims,” for example, that the product “literally BLOCKS FAT From Forming.”

Settling the case this week, the FTC imposed a fine of $12.8 million, with $50,000 due immediately and the rest suspended upon specific conditions.

In addition, Cure Encapsulations has been ordered to contact customers who bought the supplement, and to inform Amazon that it used fake, paid-for reviews.

The company has also been banned from making the same or similar products unless it has “competent and reliable scientific evidence” of their effectiveness in the form of human clinical testing.

“People rely on reviews when they’re shopping online,” Andrew Smith, director of the FTC’s Bureau of Consumer Protection, said in a release. “When a company buys fake reviews to inflate its Amazon ratings, it hurts both shoppers and companies that play by the rules.”

Whether the FTC’s recent action marks the start of a more concerted effort to tackle the issue of fake, paid-for reviews remains to be seen.

Amazon is known to go after merchants that buy fake reviews as well as the companies that supply them, but insists the “vast majority” of reviews on its site are authentic.

The company told Digital Trends it welcomes the FTC’s work in this area, adding, “Amazon invests significant resources to protect the integrity of reviews in our store because we know customers value the insights and experiences shared by fellow shoppers.”

It said it has “clear participation guidelines for both reviewers and selling partners,” and, when necessary, acts against those who violate its policies.

Not sure if that super-positive Amazon review for an item you’re interested in is fake? Then follow Digital Trends’ top tips to find out.

Updated on February 28, 2019: Added statement from Amazon.

In the first case of its kind, the Federal Trade Commission took action against a diet pill seller for both making false claims and paying to juice their standing on Amazon with fake positive reviews.

The fruit of garcinia cambogia has been hailed by some as a powerful weight loss supplement. Of course, there’s no conclusive scientific evidence to support this—although there is some indication that in rare cases it may lead to liver failure, which led the FDA to issue a notice about a product containing the active ingredient—which is why most purveyors of junk diet pills tend to make their efficacy claims vague. Cure Encapsulations, which the FTC ruled against yesterday, had no such modesty, instead stating that the extract in question “Literally BLOCKS FAT From Forming.”

Advertisement

What differentiates this from every other fake weight loss panacea fiasco is that Naftula Jacobowitz, the owner/operator of Cure Encapsulations, “paid a website, amazonverifiedreviews.com, to create and post Amazon reviews of their product,” according to the FTC—demanding his products retain an average rating of 4.3 stars. As the world’s largest ecommerce marketplace, Amazon has become ground zero for cutthroat tactics in achieving greater product visibility—among which fake reviews are a well-worn method. According to one Pew Research study, the majority of Americans sometimes check online reviews, though only around half believe they’re trustworthy.

Unsurprisingly, Jacobowitz was previously sued by another Amazon seller in 2016 for, among other things submitting “false negative feedback and/or other false complaints to Amazon.com,” which the plaintiff claimed caused her to lose the coveted Amazon ‘Buy Box,’ a piece of screen real estate associated with higher sales. (The case was settled via permanent injunction in September of 2016.)

Amazon itself has taken legal action over the years on multiple occasions against entities abusing its review system, but this case marks the first time the FTC has involved itself in these matters. “We welcome the FTC’s work in this area. Amazon invests significant resources to protect the integrity of reviews in our store because we know customers value the insights and experiences shared by fellow shoppers,” an Amazon spokesperson told Gizmodo. “Even one inauthentic review is one too many.”

Advertisement

Recommended in the ruling, and pending judgment in New York’s Eastern District Court, are a variety of stipulations against Jacobowitz’s Cure Encapsulations. His company would be required to notify prior customers of the claims against it and identify the paid reviews for Amazon. The company would also no longer be able to make “weight-loss, appetite-suppression, fat-blocking, or disease-treatment claims” about products without “reliable scientific evidence in the form of human clinical testing,” and face a largely suspended fine of $12.8 million.

Updated with comment from Amazon